Butalbital is a barbiturate with an intermediate duration of action. Butalbital is often combined with other medications, such as paracetamol (acetaminophen) or aspirin, for the treatment of pain and headache.
This report contains market size and forecasts of Butalbital in global, including the following market information:
Global Butalbital Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Butalbital Market Sales, 2017-2022, 2023-2028, (Kg)
Global top five Butalbital companies in 2021 (%)
The global Butalbital market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Tablets Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Butalbital include Alvogen, Mayne Pharma, Teva, Novartis and SUNRISEPHARMA, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Butalbital manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Butalbital Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Butalbital Market Segment Percentages, by Type, 2021 (%)
Tablets
Capsules
Global Butalbital Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Butalbital Market Segment Percentages, by Application, 2021 (%)
Retail Pharmacies
Hospital Pharmacies
Online Pharmacies
Global Butalbital Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Butalbital Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Butalbital revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Butalbital revenues share in global market, 2021 (%)
Key companies Butalbital sales in global market, 2017-2022 (Estimated), (Kg)
Key companies Butalbital sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Alvogen
Mayne Pharma
Teva
Novartis
SUNRISEPHARMA